DiaSorin Financial Statements From 2010 to 2024
| 34D Stock | EUR 104.05 0.95 0.90% |
Check DiaSorin SpA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DiaSorin SpA's main balance sheet or income statement drivers, such as , as well as many indicators such as . DiaSorin financial statements analysis is a perfect complement when working with DiaSorin SpA Valuation or Volatility modules.
DiaSorin |
DiaSorin SpA Company Current Valuation Analysis
DiaSorin SpA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current DiaSorin SpA Current Valuation | 8.48 B |
Most of DiaSorin SpA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DiaSorin SpA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, DiaSorin SpA has a Current Valuation of 8.48 B. This is 40.93% lower than that of the Healthcare sector and 8.81% higher than that of the Diagnostics & Research industry. The current valuation for all Germany stocks is 48.97% higher than that of the company.
DiaSorin SpA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DiaSorin SpA's current stock value. Our valuation model uses many indicators to compare DiaSorin SpA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DiaSorin SpA competition to find correlations between indicators driving DiaSorin SpA's intrinsic value. More Info.DiaSorin SpA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DiaSorin SpA is roughly 2.20 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DiaSorin SpA's earnings, one of the primary drivers of an investment's value.About DiaSorin SpA Financial Statements
DiaSorin SpA stakeholders use historical fundamental indicators, such as DiaSorin SpA's revenue or net income, to determine how well the company is positioned to perform in the future. Although DiaSorin SpA investors may analyze each financial statement separately, they are all interrelated. For example, changes in DiaSorin SpA's assets and liabilities are reflected in the revenues and expenses on DiaSorin SpA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DiaSorin SpA. Please read more on our technical analysis and fundamental analysis pages.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital analysis laboratories worldwide. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN S operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1928 people.
Currently Active Assets on Macroaxis
Other Information on Investing in DiaSorin Stock
DiaSorin SpA financial ratios help investors to determine whether DiaSorin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.